MKI67 and glioblastoma: In the orthotopic mouse model of GBM, [25], treatment of GSCs with BafA1 was sufficient to slow tumor growth (Fig. 1a,b), and to decrease tumor cell invasion (STEM121), proliferation (Ki67) and growth (p-S6) (Fig. 1c).